Allt inom Interim
Nanexa publishes interim report for January – September 2022
Launch of NEX-22 in type 2 diabetes and new partner projects with great potential
Nanexa publishes interim report for January – June 2022
The pilot plant inaugurated and GMP certified, patent approved in Europe and product projects approaching clinical phase